Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| Arwa | Other Identifier | self funding |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Children presented with manifestations of Cow Milk Protein Allergy will be enrolled for Cow Milk -related Symptoms Score (CoMiSS assessment). Detailed History, nutritional and clinical examination will be done to fulfill items of CoMiSS. Children will be randomly allocated to two groups. Oral Zinc will be supplemented to the interventional group. CoMiSS will be recorded at the baseline and weekly till 4 weeks. Then Oral Food Challenge (OFC) will be done to confirm the diagnosis and CoMiSS assessment will be recorded again to see if Zinc has any modulatory effect on reappearance of symptoms. The people administering the intervention, the people assessing the outcomes, the patients and their caregivers will all be blinded to the type of treatment.
Children who will be presented with skin manifestation will be assessed by Severity Scoring of Atopic Dermatitis Index (SCORAD score) once diagnosed and weekly till 4 weeks after zinc supplementation to see if Zinc has any modulatory effect.
Children who will be presented with manifestations of Cow Milk Protein Allergy will be enrolled in the study for Cow Milk -related Symptoms Score (CoMiSS) assessment.
Detailed History, nutritional and clinical examination will be done to fulfill items of CoMiSS including skin manifestations as eczema , respiratory manifestations, GIT manifestations as constipation or diarrhea including Bristol scale and regurgitations and duration of crying .
Children will be randomly allocated to two groups. Randomization will be done using GraphPad QuickCalcs software to allocate into either the interventional or control group. Oral Zinc will be supplemented to the interventional group on adose of 30 mg elemental zinc/day.
CoMiSS will be recorded at the baseline and weekly till 4 weeks. Then Oral Food Challenge (OFC) will be done to confirm the diagnosis and CoMiSS assessment will be recorded againto see if Zinc has any modulatory effect on reappearance of symptoms. The people administering the intervention, the people assessing the outcomes, the patients and their caregivers will all be blinded to the type of treatment.
Children who will be presented with skin manifestation will be assessed by Severity Scoring of Atopic Dermatitis Index (SCORAD score) once diagnosed and weekly till 4 weeks after zinc supplementation to see if Zinc has any modulatory effect.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| interventional group | Experimental | Oral Zinc will be supplemented to the interventional group on a dose of 30 mg elemental zinc/day. |
|
| control group | Placebo Comparator | oral placebo identical to Zinc inappearance and packaging |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Oral zinc supplementation | Drug | Oral Zinc will be supplemented to the interventional group on a dose of 30 mg elemental zinc/day. |
|
| Measure | Description | Time Frame |
|---|---|---|
| COMISS(Cow Milk Related symptom Score) | Evaluate the degree of change in COMISS Sc0re(Cow Milk Related symptom Score) between the interventional group and control group The COMISS Score ranges from 0 to 33. Each symptom has a maximal score of six,exception of respiratory symptoms(maximal score of three). a cut-off value>12 was selected as the criterion to pick up infant at risk of Cow Milk Allergy . A score of 12 requires the presence of at least two severe symptoms and a score higher than10 requires the precense of at least three symptoms and the involvement of two organ systems | 2 weeks |
| Measure | Description | Time Frame |
|---|---|---|
| COMISS (Cow Milk Related Symptom Score)and SCORAD (Severity Scoring of Atopic Dermatitis index) |
2.Time to improvement of COMISS score below 12 in both groups. |
Not provided
Inclusion Criteria:
Children suspected to have Cow Milk Protein Allergy using Cow's Milk-relatedSymptoms Score with a Score more than12 Age less than 12 years old both sexes Whose parents approved to be enrolled in the study
Exclusion Criteria:
Children with Comorbidities that may affect the duration of treatment as dysphagia.
History of Severe allergic reaction that required hospital admission as Ora Food Challenge is expectedto be delayed in these patients.
-Multiple Food Allergies
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Nabil Abdelaziz, Professor of Pediatrics | Cairo University | Principal Investigator |
| Dalia Sayed Mosallam, Professor of Pediatrics | Cairo University | Principal Investigator |
| Hoda Atef Abdel Sattar, Lecturer of Pediatrics | Cairo University | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| faculty of medicine-Cairo universty | Giza | 12556 | Egypt |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
one group will receive oral Zinc therapy while the other group will recieve placebo
Not provided
Not provided
Not provided
| Placebo | Other | Oral |
|
| 4 Weeks |